GILEAD GS-US-223-1017

Investigator: Mahendra Jain, MD

Study Coordinator: Bela Jain

Status: Open Not Enrolling Number: NCT04026165

Phone: 281.485.3434

Protocol Number: Pro00022451


To evaluate whether selonsertib (SEL) can slow the decline in kidney function, reduce the risk of kidney failure, or reduce the risk of death due to kidney disease in subjects with diabetic kidney disease (DKD)
More to Explore